Altiazem Retard

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

41 Suppliers, 20 USDMF, 8 CEP/COS, 5 JDMF, 4 EU WC, 6 KDMF, 17 NDC API, 22 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

1 Suppliers

1 Suppliers

DOSSIERs // Finished Dosage Forms

337 Dossiers, 214 FDA Orange Book, 27 Europe, 70 Canada, 7 South Africa, 19 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 120MG, TABLET;ORAL - 30MG, TABLET;ORAL - 60MG, TABLET;ORAL - 90MG, CAPSULE, EXTENDED RELEASE;ORAL - 120MG, CAPSULE, EXTENDED RELEASE;ORAL - 180MG, CAPSULE, EXTENDED RELEASE;ORAL - 240MG, CAPSULE, EXTENDED RELEASE;ORAL - 300MG, CAPSULE, EXTENDED RELEASE;ORAL - 360MG, CAPSULE, EXTENDED RELEASE;ORAL - 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 120MG, CAPSULE, EXTENDED RELEASE;ORAL - 180MG, CAPSULE, EXTENDED RELEASE;ORAL - 240MG, CAPSULE, EXTENDED RELEASE;ORAL - 300MG, CAPSULE, EXTENDED RELEASE;ORAL - 360MG, CAPSULE, EXTENDED RELEASE;ORAL - 420MG, TABLET, EXTENDED RELEASE;ORAL - 120MG, TABLET, EXTENDED RELEASE;ORAL - 180MG, TABLET, EXTENDED RELEASE;ORAL - 240MG, TABLET, EXTENDED RELEASE;ORAL - 300MG, TABLET, EXTENDED RELEASE;ORAL - 360MG, TABLET, EXTENDED RELEASE;ORAL - 420MG

RELATED EXCIPIENT COMPANIES

Suppliers, 33 Roquette, 32 BASF, 31 Kerry, 22 Corel Pharma Chem, 19 SPI Pharma, 19 Microlex e.U, 14 Seppic, 13 Ideal Cures Pvt Ltd, 11 Gangwal Healthcare, 11 Sigachi Industries, 11 Gangwal Chemicals, 10 Actylis, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 Nanjing Well Pharmaceutical, 6 Lonza Capsugel, 5 Kima Chemical, 5 Boai NKY Pharmaceuticals Ltd, 5 Evonik, 5 DFE Pharma, 4 ACG Worldwide, 4 The Dow Chemical Company, 4 Rochem International Inc, 4 DKSH, 4 Ingredion Pharma Solutions, 3 Prachin Chemical, 3 Vertellus, 3 Ulanqab Kema New Material, 3 Vasa Pharmachem, 2 Nomisma Healthcare, 2 Qualicaps, 2 Pharmatrans-Sanaq, 2 Shijiazhuang Huaxu Pharmaceutical, 2 Alcedo Pharmachem, 2 Seqens, 2 Finar, 2 Pfanstiehl, 2 Jai Radhe Sales, 1 Zhejiang Huakang Pharmaceutical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Aeon Procare, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Nanjing Bold Chemical

EXCIPIENTS BY APPLICATIONS

95 Fillers, Diluents & Binders, 72 Coating Systems & Additives, 58 Controlled & Modified Release, 41 Direct Compression, 36 Solubilizers, 30 Thickeners and Stabilizers, 29 Granulation, 29 Taste Masking, 28 Film Formers & Plasticizers, 23 Disintegrants & Superdisintegrants, 21 Lubricants & Glidants, 20 Parenteral, 17 Chewable & Orodispersible Aids, 17 Co-Processed Excipients, 14 Topical, 9 Emulsifying Agents, 9 Empty Capsules, 7 API Stability Enhancers, 6 Rheology Modifiers, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

101 US Medicaid Prescriptions, 72 Finished Drug Prices

MARKET PLACE

13 APIs, 1 DOSSIERS // FDF

PATENTS

25 Health Canada Patents

25 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 Analytical Solutions, 3 EDQM Standards, 3 USP Standards, 2 Other Ref. Standards

DIGITAL CONTENT

29 News

29 News

Information, Expiry & Status of Health Canada Patents covering Altiazem Retard.

Altiazem Retard

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

41 Suppliers

20 USDMF

8 CEP/COS

5 JDMF

4 EU WC

6 KDMF

17 NDC API

22 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

1 Suppliers

DOSSIERs // Finished Dosage Forms

337 Dossiers

214 FDA Orange Book

27 Europe

70 Canada

7 South Africa

19 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 120MG

TABLET;ORAL - 30MG

TABLET;ORAL - 60MG

TABLET;ORAL - 90MG

CAPSULE, EXTENDED RELEASE;ORAL - 120MG

CAPSULE, EXTENDED RELEASE;ORAL - 180MG

CAPSULE, EXTENDED RELEASE;ORAL - 240MG

CAPSULE, EXTENDED RELEASE;ORAL - 300MG

CAPSULE, EXTENDED RELEASE;ORAL - 360MG

CAPSULE, EXTENDED RELEASE;ORAL - 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 120MG

CAPSULE, EXTENDED RELEASE;ORAL - 180MG

CAPSULE, EXTENDED RELEASE;ORAL - 240MG

CAPSULE, EXTENDED RELEASE;ORAL - 300MG

CAPSULE, EXTENDED RELEASE;ORAL - 360MG

CAPSULE, EXTENDED RELEASE;ORAL - 420MG

TABLET, EXTENDED RELEASE;ORAL - 120MG

TABLET, EXTENDED RELEASE;ORAL - 180MG

TABLET, EXTENDED RELEASE;ORAL - 240MG

TABLET, EXTENDED RELEASE;ORAL - 300MG

TABLET, EXTENDED RELEASE;ORAL - 360MG

TABLET, EXTENDED RELEASE;ORAL - 420MG

RELATED EXCIPIENT COMPANIES

Suppliers

33 Roquette

32 BASF

31 Kerry

22 Corel Pharma Chem

19 SPI Pharma

19 Microlex e.U

14 Seppic

13 Ideal Cures Pvt Ltd

11 Gangwal Healthcare

11 Sigachi Industries

11 Gangwal Chemicals

10 Actylis

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

7 Nanjing Well Pharmaceutical

6 Lonza Capsugel

5 Kima Chemical

5 Boai NKY Pharmaceuticals Ltd

5 Evonik

5 DFE Pharma

4 ACG Worldwide

4 The Dow Chemical Company

4 Rochem International Inc

CAPSULE, EXTENDED RELEASE;ORAL - 120MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 180MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 240MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons